These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17665213)

  • 21. [Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
    Chai LP; Su ZZ; Xian ZX
    Ai Zheng; 2003 Apr; 22(4):372-5. PubMed ID: 12703991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
    Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
    Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients.
    Elias D; Goere D; Blot F; Billard V; Pocard M; Kohneh-Shahri N; Raynard B
    Ann Surg Oncol; 2007 Jun; 14(6):1818-24. PubMed ID: 17356950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
    Liang YJ; Fu LW; Ding Y; Xiong HY; Chen LM; Yang XP; Pan QC
    Ai Zheng; 2003 Apr; 22(4):368-71. PubMed ID: 12703990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
    BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of peritoneal carcinomatosis in mice by combining hyperthermal intraperitoneal chemotherapy with the water extract from Burr parsley (Caucalis platycarpos L.).
    Orsolić N; Bevanda M; Kujundzić N; Plazonic A; Stajcar D; Kujundzić M
    Planta Med; 2010 May; 76(8):773-9. PubMed ID: 20033866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
    Wang AX; Li S; Ding XQ; Chen Y; Chen D
    Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
    Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
    Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.
    Péron JM; Bureau C; Gourdy P; Lulka H; Souque A; Calippe B; Selves J; Al Saati T; Bernad J; Cordelier P; Couderc B; Pradayrol L; Pipy B; Buscail L; Vinel JP
    Gut; 2007 Jan; 56(1):107-14. PubMed ID: 16891358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice.
    Dai M; Xu X; Song J; Fu S; Gou M; Luo F; Qian Z
    Cancer Lett; 2011 Dec; 312(2):189-96. PubMed ID: 21943824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study.
    Shao LH; Liu SP; Hou JX; Zhang YH; Peng CW; Zhong YJ; Liu X; Liu XL; Hong YP; Firestone RA; Li Y
    Cancer; 2012 Jun; 118(11):2986-96. PubMed ID: 22006342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
    Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil.
    Lin YL; Zhang J; Yan FC; Jiang X; Ma R; Yang ZR; Xu HB; Peng Z; Chen Q; Li Y
    Cancer Med; 2020 Feb; 9(3):1104-1114. PubMed ID: 31814323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.
    Simón-Gracia L; Hunt H; Scodeller PD; Gaitzsch J; Braun GB; Willmore AM; Ruoslahti E; Battaglia G; Teesalu T
    Mol Cancer Ther; 2016 Apr; 15(4):670-9. PubMed ID: 26880267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.
    Muñoz-Casares FC; Rufián S; Arjona-Sánchez Á; Rubio MJ; Díaz R; Casado Á; Naranjo Á; Díaz-Iglesias CJ; Ortega R; Muñoz-Villanueva MC; Muntané J; Aranda E
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):267-74. PubMed ID: 21499894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study.
    Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S475-82. PubMed ID: 21837528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis.
    Elias D; Raynard B; Boige V; Laplanche A; Estphan G; Malka D; Pocard M
    J Surg Oncol; 2005 Jun; 90(4):220-5. PubMed ID: 15906364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model.
    Monneuse O; Mestrallet JP; Quash G; Gilly FN; Glehen O
    J Gastrointest Surg; 2005; 9(6):769-74. PubMed ID: 15985231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.